Alunbrig 180 mg (Brigatinib TABLET) 180 MG

Alunbrig 180 mg tablets contain brigatinib, a medication used for targeted therapy. This oral treatment is designed for specific medical conditions and is manufactured by Takeda Canada Inc.

Strength

180 MG

Pack Size

21/28/30

Manufacturer / TM Owner

TAKEDA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Alunbrig 180 mg tablets are primarily used in targeted therapy for certain types of cancer. Brigatinib, the active ingredient, is often prescribed for conditions where specific proteins are involved. Patients may wonder, 'What is brigatinib used for?' and the answer typically involves its role in managing advanced or metastatic cancers.

Side Effects

Common effects of Alunbrig 180 mg tablets may include nausea, fatigue, and cough. Some users might experience changes in taste or shortness of breath. These effects can vary from person to person and are not exhaustive.

Precautions & Warnings

Alunbrig 180 mg tablets should be handled with care, following the guidance of a healthcare provider. It is important to store the medication properly and to be aware of potential side effects. Always consult a healthcare professional before starting any new medication.

Avoid Interactions

Alunbrig 180 mg tablets may interact with certain medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the efficacy of brigatinib.

Frequently Asked Questions

Brigatinib is used in targeted therapy for specific types of cancer, often involving certain proteins.

Alunbrig 180 mg tablets should be stored as directed by the healthcare provider, typically at room temperature.

Common side effects may include nausea, fatigue, and cough, among others.

Potential interactions with other medications should be discussed with a healthcare provider.

Long-term use should be monitored by a healthcare provider to ensure safety and efficacy.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.